title: High-dose intravenous immunoglobulin (IVIG) adjuvant therapy for cell-mediated pancreas transplant rejection.
authors.forename: Choli
authors.initials: C
authors.lastname: Hartono
authors.forename: Jim
authors.initials: J
authors.lastname: Kim
authors.forename: Jennifer
authors.initials: J
authors.lastname: McDermott
authors.forename: Surya V
authors.initials: SV
authors.lastname: Seshan
authors.forename: David
authors.initials: D
authors.lastname: Serur
mesh_terms: D000328:Adult; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D016035:Pancreas Transplantation / Q000009:adverse effects*; D014184:Transplantation, Homologous
chemical_list: D016756:Immunoglobulins, Intravenous